journal article·2026-12-31Open access

The mechanism of Gei Herba against type 2 diabetes mellitus: an integration of gut microbiota and network pharmacology analysis

Xi-Mei Zhang, Hao-Ming Zhou, Wen-Xiao Wang, Yong-Gang Wu, Yi-Xin Zhang, Shi-Jun Yue

Abstract

The present study aimed to dissect the underlying mechanism of the Gei Herba (LBZ) in the treatment of type 2 diabetes mellitus (T2DM) based on the gut microbiota and network pharmacology strategies. Thirty-one compounds from LBZ were screened and 187 corresponding targets were identified through the database and literature screening. Multiple disease-associated gene and target databases were used to screen and obtain 726 T2DM-related targets. The gutMGene v1.0 database was used for searching metabolites and targets of gut microbiota. 168 overlapping targets of LBZ, T2DM and the gut microbiota were matched and used to build a protein-protein interaction network and perform enrichment analysis. By bioinformatics analysis of microbiota-pathway-target-compound network, the PI3K-Akt signalling pathway was identified, and potential gut probiotics, such as Eubacterium limosum and Lactobacillus paracasei, were found. Subsequently, the core active compounds in LBZ bind to the core targets were verified by molecular docking, all of which exhibited good binding affinity. Finally, four compounds, eleutheroside A, gallic acid, kaempferol, and protocatechuic acid, were found to conform to Lipinski’s rule and be non-toxic, showing great potential in the treatment of T2DM. These findings suggest the potential mechanism of LBZ in the treatment of T2DM and the core compounds, such as eleutheroside A may be the promising candidates for T2DM treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gut microbiota and health · Berberine and alkaloids research · Natural Antidiabetic Agents Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Shaanxi University of Chinese Medicine

International Joint Research Center on Resource Utilization and Quality Evaluation of Traditional Chinese Medicine of Hebei Province, Hebei University of Chinese Medicine

Funding

Scientific Research Projects of Higher Education Institutions in Hebei Province

References (36)

Show source-provided references
1. 10.2147/DMSO.S30479610.2147/DMSO.S304796 ↗
2. 10.3389/fcimb.2022.83448510.3389/fcimb.2022.834485 ↗
3. 10.3389/fendo.2022.95821810.3389/fendo.2022.958218 ↗
4. 10.1016/j.dsx.2025.10320810.1016/j.dsx.2025.103208 ↗
5. Hong XF, Wan YS, Gao Y, et al. The experimental study on the decreasing blood sugar of Aleppo Avens on mice of high blood sugar. J Dali Univ. 2007;10:7–9.
6. 10.1016/j.indcrop.2024.11967910.1016/j.indcrop.2024.119679 ↗
7. 10.19540/j.cnki.cjcmm.20230428.20110.19540/j.cnki.cjcmm.20230428.201 ↗
8. 10.1016/j.jpha.2023.05.01210.1016/j.jpha.2023.05.012 ↗
9. 10.1016/j.jpha.2024.10110510.1016/j.jpha.2024.101105 ↗
10. 10.1016/j.jsbmb.2025.10686310.1016/j.jsbmb.2025.106863 ↗
11. 10.1016/j.amolm.2024.10006010.1016/j.amolm.2024.100060 ↗
12. 10.1080/21691401.2024.235047510.1080/21691401.2024.2350475 ↗
13. Yang Z, Gao H, Zhou HM, et al. Establishment of HPLC fingerprints for Geum japonicum var. chinense and determination of eight constituents. Chin Herb Med. 2023;45(01):123–126.
14. Zhao RR, Zhang JY, Zhou XM. Studies on the chemical constituents, quality control and pharmacological effects of Miao medicine Gei Herba. J Zunyi Med Univ. 2017;40(05):568–578.
15. Tao W, Wang K, Wang JF, et al. Research progress on chemical ingredients of Aleppo Avens and their pharmacological effects. Chin Herb Med. 2018;49(01):233–238.
16. 10.1111/jcmm.1778710.1111/jcmm.17787 ↗
17. 10.3389/fendo.2021.75658110.3389/fendo.2021.756581 ↗
18. 10.1111/dom.1636610.1111/dom.16366 ↗
19. 10.1016/j.phymed.2025.15674610.1016/j.phymed.2025.156746 ↗
20. 10.1016/j.eclinm.2024.10298210.1016/j.eclinm.2024.102982 ↗
21. 10.1007/s11010-022-04587-x10.1007/s11010-022-04587-x ↗
22. 10.1007/s13300-025-01743-610.1007/s13300-025-01743-6 ↗
23. 10.1016/j.ijbiomac.2024.12995010.1016/j.ijbiomac.2024.129950 ↗
24. 10.1016/s0960-9822(03)00378-610.1016/s0960-9822(03)00378-6 ↗
25. 10.1055/s-2008-108148610.1055/s-2008-1081486 ↗
26. 10.1111/1753-0407.1251610.1111/1753-0407.12516 ↗
27. 10.1080/07853890.2022.206454110.1080/07853890.2022.2064541 ↗
28. 10.3121/cmr.2023.174310.3121/cmr.2023.1743 ↗
29. He ML, Wang X, He CZ, et al. Prediction of quality markers of Xuefu Zhuyu Capsule based on chemical composition, pharmacological action and network pharmacology. Chin Herb Med. 2024;55(11):3886–3897.
30. Li CM, Luo W. Research progress on the mechanism of type 2 diabetes-related pathogenic genes. Shandong Yiyao. 2024;64(14):95–100.
31. 10.1038/s41598-023-49679-w10.1038/s41598-023-49679-w ↗
32. 10.1039/c8fo00081f10.1039/c8fo00081f ↗
33. 10.3389/fphar.2017.0025110.3389/fphar.2017.00251 ↗
34. 10.1016/j.etap.2020.10357710.1016/j.etap.2020.103577 ↗
35. 10.3389/fphar.2024.137371110.3389/fphar.2024.1373711 ↗
36. 10.1016/j.nexus.2024.10035110.1016/j.nexus.2024.100351 ↗